Concepedia

Ryo Iwamura

RI

Statistics

Publications

8

Citations

432

H-Index

8

Active since

2001

Affiliations

Ube (Japan)(Current)

Santen (United States)

Santen (Japan)

Ryo Iwamura is an author at Ube (Japan) specializing in pharmacology, medicine, and ocular pharmacodynamics.

ORCID

Publications per year

2001–2021

8

Publications

8

Antiplatelet action of R‐99224, an active metabolite of a novel thienopyridine‐type G<sub>i</sub>‐linked P2T antagonist, CS‐747

Atsuhiro Sugidachi, Fumitoshi Asai, Kenji Yoneda et al. · British Journal of Pharmacology · 2001 · 110 citations · Full text

, , +16

Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular Hypotensive Agent

Tomoko Kirihara, Takazumi Taniguchi, Kenzo Yamamura et al. · Investigative Ophthalmology & Visual Science · 2018 · 93 citations · Full text

, , +12

Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys

Masahiro Fuwa, Carol B. Toris, Shan Fan et al. · Journal of Ocular Pharmacology and Therapeutics · 2018 · 91 citations · Full text

, , +15

Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl

Ryo Iwamura, Masayuki Tanaka, Eiji Okanari et al. · Journal of Medicinal Chemistry · 2018 · 52 citations · Full text

, , +10

Effects of the Selective EP2 Receptor Agonist Omidenepag on Adipocyte Differentiation in 3T3-L1 Cells

Yasuko Yamamoto, Takazumi Taniguchi, Tomoaki Inazumi et al. · Journal of Ocular Pharmacology and Therapeutics · 2020 · 31 citations · Full text

, , +14

1–5 of 8